ImmuPharma Competitors and Similar CompaniesClear all
Quark Pharmaceuticals's competitors and similar companies include Cambridge Epigenetix and Advanced Accelerator Applications.
 Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. |  Cambridge Epigenetix Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw. |  Advanced Accelerator Applications Advanced Accelerator Applications is a radiopharmaceutical company, develops, produces, and commercializes radiolabeled pharmaceuticals and diagnostic nuclear medicines in France and internationally. | |
Founding Date | Founding Date 1994 | Founding Date 2012 | Founding Date 2002 |
Type | Type Private | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Newark, US HQ | Locations Little Chesterford, GB HQ Wilmslow, GB | Locations Saint-Genis-Pouilly, FR HQ Genève, CH |
Employees | Employees 781% decrease | Employees 1121% decrease | Employees 7383% decrease |
Funding | |||
Latest funding round | Latest funding round $ 10m (almost 16 years ago) | Latest funding round $ 30m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 37m | Total funding raised $ 56.5m | Total funding raised $ 52.8m |
For sources of this data, please see the company profile
View Company Profiles
Cambridge Epigenetix
HQ
Little Chesterford, GB
Employees
112↓ 1% decrease
Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
View companyAdvanced Accelerator Applications
HQ
Saint-Genis-Pouilly, FR
Advanced Accelerator Applications is a radiopharmaceutical company, develops, produces, and commercializes radiolabeled pharmaceuticals and diagnostic nuclear medicines in France and internationally.
View company